Clinical Trial Update: Diclofenac as a KMO Inhibitor [EARLY_Phase 1]

View source ↗

Summary

The update notes an early Phase 1 clinical trial evaluating diclofenac as a kynurenine monooxygenase (KMO) inhibitor for alcohol use disorder, with the study cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Diclofenac (diclofenac)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Alcohol Use Disorder | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING